Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: A blind, randomized study of 192 patients

Effectiveness and Safety of Patient-Initiated Single-Dose versus Continuous Low-Dose Antibiotic Prophylaxis for Recurrent Urinary Tract Infections in Postmenopausal Women: A Randomized Controlled Study

“…Previous studies have shown that postcoital prophylaxis was as effective as daily prophylaxis in preventing UTIs, 18 and a single dose of 500 mg ciprofloxacin orally before urodynamic study (UDS) dramatically decreased the rate of UTIs after UDS from 14% to 1%. 19 These studies support the hypothesis that antibiotic prophylaxis could be administered intermittently before or after exposure to conditions predisposing to UTIs. Due to patient self-knowledge of UTI symptoms, some studies have shown that a positive outcome can be achieved with patients taking the initiative in recurrent UTI treatment.…”

Bacteriuria and urinary tract infection after female urodynamic studies: Risk factors and microbiological analysis

“…In accordance with many other authors, we identified E coli as the most common pathogen in women with UDS-associated UTI. 3,5,6,20 Importantly, the susceptibility profiles of community-acquired UTI (CA-UTI) of E coli and Klebsiella spp have changed in recent decades, showing a significant increase in extended-spectrum b-lactamase (ESBL) producers. 21 Recently, Salles et al reported that in Latin American countries, including Brazil, there has been an increasing prevalence of ESBL-producing E coli causing CA-UTI with resistance to cotrimoxazole, quinolones, and second-generation cephalosporins.…”

Antibiotic Use for Urodynamics: A Comprehensive Review that Informs Local Practice

“…However, bacteriuria associated symptoms were not reported in many studies. 1,3,9,23,24 Outcome measures entailed various end points ranging from 2 to 7 days after the procedure. There was little agreement on the choice of antibiotics, including dose and duration of prophylaxis.…”

“…The aim is to reduce the subsequent risk of UTI, which is a well recognized complication. 1 Opinions differ regarding whether antibiotics should be given routinely to everyone or whether they should be confined to high risk groups only. 1e4 High risk patients have been described in the literature as those with a known increased risk of infections, such as those with neurogenic bladder, spinal cord injury, advanced age, diabetes mellitus, prolonged hospitalization, indwelling catheter, recurrent UTI, transplant recipient or immunodeficiency.…”